TRIFERIC® (ferric pyrophosphate citrate) solution
This slideshow reviews drug information for TRIFERIC, indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease.
Metabolic Syndrome was present in 74.5% of the cohort.
Waist-to-height ratio may be a usefulanthropometric predictor of metabolicsyndrome (MetS) in patients onmaintenance hemodialysis (HD), a newstudy suggests.
Jacqueline Costa Teixeira Caramori,MD, PhD, and colleagues at the UniversidadeEstadual Paulista in São Paulo,Brazil, conducted a cross-sectionalstudy of 98 maintenance HD patients(mean age 57.8 years, 54% male). MetS was present in 74.5% of the cohort.Patients with MetS had increasedaccumulation of abdominal fat andgeneral obesity. Waist-to-height ratiowas the best independent predictor ofMetS, followed by waist circumferenceand body mass index, the researchersreported in Nutrition in Clinical Practice(published online ahead of print).
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.